International Clinical Trial: Tofacitinib versus Dutasteride in the treatment of Frontal Fibrosing Alopecia

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (RBR-3jm8ksc) titled 'Tofacitinib versus Dutasteride in the treatment of Frontal Fibrosing Alopecia' on July 22.

Study Type: Intervention

Study Design: n/a, randomized-controlled, triple-blind

Primary Sponsor: Hospital Universitario Pedro Ernesto

Condition: Alopecia Skin and Connective Tissue Diseases

Intervention: This is a randomized, controlled, triple-blind, single-center, two-arm parallel clinical trial involving 50 participants with frontal fibrosing alopecia and inflammatory signs. Participants will be randomly allocated in a one-to-one ratio using a computer-generated randomization sequence, with 25 participants assigned to ...